T he administration of cognitive screening instruments (CSIs) remains integral to diagnostic evaluation of patients with cognitive complaints, although CSIs are 'screeners' rather than diagnostic tests in themselves. Clinicians using CSIs want to be sure (or as sure as possible) that test scores can reliably distinguish the diagnostic categories of dementia, mild cognitive impairment (MCI), and subjective memory complaint (SMC), since these categories will have implications for subsequent patient investigation and treatment. Broadly speaking, dementia may be defined as acquired cognitive impairment in multiple domains sufficient to impair social and/or occupational function (of which there are many causes or subtypes, such as Alzheimer's disease, vascular dementia, dementia with Lewy bodies, frontotemporal dementias), whereas MCI may be defined as cognitive impairment short of dementia but with relative preservation of activities of daily living, again with many potential causes or subtypes. Hypothesis or significance testing may help to demonstrate whether CSIs have these desired attributes.
In a previous study, the datasets from several pragmatic prospective diagnostic test accuracy studies 1 were used to examine the hypothesis that arithmetic mean test scores for patients with dementia versus MCI, and for patients with MCI versus SMC, differed significantly (null hypothesis rejected), assuming test scores to be normally (or approximately normally) distributed. The analyses showed that several short performance-based CSIs showed statistically significant (p<0.05) differences in test scores when patients with dementia, MCI, and SMC were compared, suggesting that these CSIs might be used to identify MCI cases. 2 The assumption of normally, or approximately normally, distributed The aim of the study presented here was to collate information from pragmatic studies of selected short CSIs (ie those taking approximately 5-10 minutes to administer) to examine their screening utility for the diagnosis of MCI, versus either dementia or SMC, by calculation of geometric means using log transformation of test scores to compensate for skewed data.
Materials and methods
The datasets from three pragmatic prospective diagnostic test accuracy studies undertaken in a dedicated cognitive disorders clinic based in a regional neuroscience centre were used. These examined three short CSIs in common usage: Montreal Cognitive Assessment (MoCA), 3 Mini-Addenbrooke's Cognitive Examination (MACE), 4 and the Six-Item Cognitive Impairment Test (6CIT). 5 Of these CSIs, two -MoCA 6 and MACE 7 -had negatively skewed distributions of test scores (ie higher scores = better performance; skewed to the right; Figure 1 ); and one, 6CIT, 8 had a positively skewed distribution of test scores (ie lower scores = better performance; skewed to the left; Figure 2 ). Study details (sample size, prevalence of dementia and MCI, sex ratio, age range) are shown in Table  1 . As anticipated in this setting, the case mix had a relatively young median age (59-60 years).
All studies followed a standardised format of cross-sectional assessment of consecutive outpatient referrals with some or all of the following elements: semi-structured patient history enquiring about cognitive symptoms and functional performance, with collateral history where possible; administration of CSIs; neuroradiological examination (CT all patients; interval MR imaging in some cases), and formal neuropsychological assessment in some cases. 9 Standard diagnostic criteria for dementia (DSM-IV) and MCI (Petersen) were used. Since all referrals have at minimum subjective memory complaint (SMC), there was no 'normal' control group, as befits pragmatic (or 'phase III') diagnostic test accuracy studies.
1 Criterion diagnosis was by judgment of an experienced clinician based on diagnostic criteria but did not use CSI scores in order to avoid review bias, in accordance with suggested standards for conduct of diagnostic test accuracy studies in dementia. 10 Log transformation of CSI test scores was performed by replacing each datum value by its logarithm to base e. Since log e (0) does not exist, zero values were treated as = 0.5 for the purposes of transformation. Geometric means were calculated using the log transformed data. Means were then back transformed to give the ratio of the geometric means with 95% confidence intervals, since standard deviation cannot be back transformed.
Hypothesis or significance testing based on the null hypothesis was undertaken comparing mean test scores for patients with dementia versus MCI, and for patients with MCI versus SMC. A value of p<0.05 was taken as significant.
Results
The arithmetic mean scores for all three of the CSIs examined differed significantly (p<0.001) between dementia and MCI cases and between MCI and SMC cases (Table 2) , as previously reported. 2 Examining log transformed test scores, the geometric mean scores for all three of the CSIs examined differed significantly (p<0.001) between dementia and MCI cases and between MCI and SMC cases (Table 3) . Back transforming the geometric mean scores (Table 4) did not show arithmetic means to be less than geometric means for MoCA and MACE as might be anticipated with negatively skewed datasets. Hence there was no evidence for deflation of arithmetic means.
Conversely, for the positively skewed test, 6CIT, although the arithmetic means were numerically greater than the geometric means, because the test is negatively scored (ie lower scores = better performance) these data provided no evidence for inflation of arithmetic means as might be anticipated with positively skewed data. The ratios of geometric means (Table 4 , right hand column) may be interpreted to show the value of each test for each diagnostic differential (dementia vs MCI; MCI vs. SMC). Hence, for example, mean MoCA score for patients with MCI may be interpreted to be 46% greater than for patients with dementia with a 95% confidence interval of 32% to 60%. The ratios for 6CIT appear particularly impressive.
Discussion
Rather than some arid mathematical exercise, this study has implications of direct clinically relevance. The data reported suggest that these frequently administered short performance-based CSIs may be used to identify MCI cases with confidence despite the skewing of test scores in the patient cohorts examined. The analyses have addressed the possible objection that examining arithmetic means (ie assuming a normal distribution of test scores) is not valid because of skewed data points. The findings might also assist in setting cut-points for pragmatic use in differentiating dementia, M C I , a n d S M C w h e n u s i n g these instruments.
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Study shortcomings are similar to those in the previous analysis of CSIs for MCI diagnosis.
2 For example, the patient age range in the analysed studies is very broad, typical of the setting, with a younger median age (59-60 years) than seen in cognitive clinics based in old age psychiatry or geriatric settings where a higher prevalence of dementia and MCI would be anticipated. Significance tests are post hoc, based on aggregate data once diagnoses have been made. This is contrary to the idiom of clinical practice where diagnosis is unknown before assessment. Measures of discrimination such as sensitivity, specificity, predictive values and likelihood ratios are therefore more typically used as test descriptors (as illustrated previously for these tests for MCI diagnosis). 2 Furthermore, qualitative pattern of impairment on these tests may also be useful clinically, rather than simply using the overall test scores, since MCI patients may be anticipated to do well on certain aspects of CSIs and poorly on others (eg memory recall in amnestic MCI).
It has also been recently questioned whether the common practice of using p<0.05 as the criterion of statistical significance is reasonable; it has been argued that p<0.005 should be used instead. 12 In this context it is reassuring to see that all the calculated p values for both arithmetic and geometric means for all three CSIs examined for both differential diagnoses were p<0.001.
These findings emerge from pragmatic diagnostic (or technically 'screening') test accuracy studies. 1 Such studies based on clinic population datasets should have high external validity, with results transferable to other similar clinics and so informing day-to-day clinical practice.
In summary, the assumption of normality of test score distribution for the purposes of analysis is probably reasonable, with no necessity to correct for skewing of datasets by converting to geometric means. This assumption may need to be tested for each individual CSI, especially with newly published tests, and in different clinical settings if the prevalence of dementia/MCI differs (eg primary care and community settings versus secondary care/dedicated cognitive clinics).CSIs may therefore still be useful in the identification of patients with MCI, 2,13,14 pending the development of clinically applicable disease biomarkers.
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